U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H23BrFN5O2
Molecular Weight 488.353
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ERAS-801

SMILES

CN1CCN(C[C@H]2COC3=CC4=NC=NC(NC5=CC=CC(Br)=C5F)=C4C=C3O2)CC1

InChI

InChIKey=PHQOQKGDQRKQNK-AWEZNQCLSA-N
InChI=1S/C22H23BrFN5O2/c1-28-5-7-29(8-6-28)11-14-12-30-19-10-18-15(9-20(19)31-14)22(26-13-25-18)27-17-4-2-3-16(23)21(17)24/h2-4,9-10,13-14H,5-8,11-12H2,1H3,(H,25,26,27)/t14-/m0/s1

HIDE SMILES / InChI

Molecular Formula C22H23BrFN5O2
Molecular Weight 488.353
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 12:05:05 GMT 2025
Edited
by admin
on Wed Apr 02 12:05:05 GMT 2025
Record UNII
B68F5P9PB7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ERAS-801
Code English
(1,4)DIOXINO(2,3-G)QUINAZOLIN-4-AMINE, N-(3-BROMO-2-FLUOROPHENYL)-7,8-DIHYDRO-7-((4-METHYL-1-PIPERAZINYL)METHYL)-, (7S)-
Preferred Name English
(7S)-N-(3-bromo-2-fluorophenyl)-7-[(4-methylpiperazin-1-yl)methyl]-7H,8H-[1,4]dioxino[2,3-g]quinazolin-4-amine
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 944323
Created by admin on Wed Apr 02 12:05:05 GMT 2025 , Edited by admin on Wed Apr 02 12:05:05 GMT 2025
Code System Code Type Description
FDA UNII
B68F5P9PB7
Created by admin on Wed Apr 02 12:05:05 GMT 2025 , Edited by admin on Wed Apr 02 12:05:05 GMT 2025
PRIMARY
NCI_THESAURUS
C187232
Created by admin on Wed Apr 02 12:05:05 GMT 2025 , Edited by admin on Wed Apr 02 12:05:05 GMT 2025
PRIMARY
PUBCHEM
162532892
Created by admin on Wed Apr 02 12:05:05 GMT 2025 , Edited by admin on Wed Apr 02 12:05:05 GMT 2025
PRIMARY
CAS
2490431-16-6
Created by admin on Wed Apr 02 12:05:05 GMT 2025 , Edited by admin on Wed Apr 02 12:05:05 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
PRECLINICAL
Related Record Type Details
ACTIVE MOIETY
Treatment of malignant glioma, which includes glioblastoma (GBM).
Name Property Type Amount Referenced Substance Defining Parameters References
BRAIN/PLASMA RATIO PHARMACOKINETIC